October 5-7 | Arizona Biltmore

Avista Therapeutics

Rob Lin, CEO

Oct. 6 | 4:30pm | FLW Ballroom F

Pittsburgh, PA

(Private)

Avista Therapeutics is a preclinical gene therapy company whose mission is to break barriers in delivery of genetic medicines through AI-driven innovation. Through our ARTEMIS platform, Avista has engineered best-in-class vectors to treat retinal diseases through intravitreal injection.

www.avistatx.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions